• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Imprivata Launches Touchless Palm Vein Scanner to Address Patient Safety Concerns from COVID-19

by Fred Pennic 10/15/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Imprivata Launches Touchless Palm Vein Scanner to Address Patient Safety Concerns from COVID-19

What You Should Know:

– Imprivata launches a new palm vein scanner solution: Imprivata PatientSecure to power touchless biometric patient identification for healthcare.

– The next generation palm scanner, developed in collaboration with Keyo, will help healthcare organizations solve the challenge of patient ID amidst the COVID-19 pandemic by eliminating the need to touch any surfaces. (It’s also a core component of the Imprivata digital identity framework for healthcare, which provides a unified, security strategy for managing identities across devices and locations.)


Imprivata, the digital identity company for healthcare, has unveiled its next-generation touchless biometric patient identification solution, delivered through a combination of a next-generation palm scanner with an antimicrobial copper coating, sensor, and software. The touchless solution is the result of a collaboration between Imprivata and Keyo, whose joint expertise in biometric identification, rapid innovation, and user-centric design produced this latest advancement in digital identity management for patients. The solution enables healthcare organizations to ensure clinicians have access to patients’ correct medical records while giving patients confidence in the safety of their medical care and the security of their medical information.

PatientSecure Palm Vein Scanner for Touchless Biometric Patient identification

Imprivata PatientSecure helps solve the challenges of patient identity for the nation’s largest and most complex healthcare organizations by combining the best of modern patient matching technologies – namely biometric and referential matching – to securely and accurately match patients to their medical records using a process of in-person identity proofing, advanced record resolution, and authentication. Imprivata PatientSecure is a core component of the Imprivata digital identity framework for healthcare, a unified, security- and efficiency-focused strategy for managing identities across the complex healthcare ecosystem. 

Why Palm Vein Biometrics?

Palm vein biometrics are less intrusive than other biometric technologies and among the most accurate. With touchless authentication, patient risk of infection is also reduced. Palm vein scanning can be used in any workflow but is the only biometric that can be used for non-responsive patient identification. The solution can also be taken mobile on WOWs and tablets for bedside registration and other points of care. 

In addition to being touchless, the scanner features an antimicrobial copper coating, which kills 99.9% of bacteria*. So, aside from routine hygiene practices, such as hand washing and disinfecting, copper adds another layer of hygiene to surfaces by continuously killing harmful bacteria and microbes. In addition, the scanners are easy to clean, fast, and intuitive to use.

Why It Matters

With the outbreak of COVID-19, both patients and provider organizations experienced heightened awareness and concern about the risk of transmission from frequently touched surfaces. Working together, Imprivata and Keyo addressed this challenge head-on, to bring the next generation of advanced biometric identity technology to healthcare institutions. By elevating Imprivata PatientSecure to a touchless solution, Imprivata ensures positive patient identification while limiting risks of transmission.       

– With its touchless patient identification solution, Imprivata PatientSecure helps healthcare organizations achieve the following goals:

– Improve patient safety and reduce medical errors;

– Enhance patient experience and streamline workflows with touchless authentication;

– Protect against fraud and eliminate duplicate and overlaid medical records; and 

– Reduce medical claim denials and improve financial outcomes.

“Patients are expecting a safe and streamlined experience as they return to physical locations for medical care amidst the COVID-19 pandemic,” said Dr. Sean Kelly, Chief Medical Officer at Imprivata. “We’re pleased to help our customers meet those expectations with the touchless biometric identification, improved patient matching, and workflow optimization offered with the latest version of Imprivata PatientSecure.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Biometric Data, Biometric Patient Identification, Coronavirus (COVID-19), Imprivata, medical records, Patient Experience, patient safety, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |